Exploring the efficacy and safety of acupuncture versus sham acupuncture for diminished ovarian reserve: study protocol for a multicentre randomised controlled trial
Yang Wang,
Jian Wang,
Li Chen,
Jie Yang,
Li Yang,
Huanfang Xu,
Yigong Fang,
Jie Hu,
Qiwei Xiao,
Yixuan Feng,
Yumi Wu,
Chenchen Su,
Lixia Pei,
Jiashan Li,
Weixin Li,
Minghui Gou
Affiliations
Yang Wang
Guang`anmen Hospital of CACMS, Beijing, China
Jian Wang
The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China
Li Chen
Nanjing Jinling Hospital, Nanjing, China
Jie Yang
Chengdu Xinan Gynecology Hospital, Chengdu, China
Li Yang
Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences (CACMS), Beijing, China
Huanfang Xu
Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences (CACMS), Beijing, China
Yigong Fang
Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences (CACMS), Beijing, China
Jie Hu
Wang Jing Hospital of CACMS, Beijing, China
Qiwei Xiao
Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences (CACMS), Beijing, China
Yixuan Feng
Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences (CACMS), Beijing, China
Yumi Wu
Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences (CACMS), Beijing, China
Chenchen Su
Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences (CACMS), Beijing, China
Lixia Pei
Jiangsu Province Hospital of Chinese Medicine, Nanjing, China
Jiashan Li
Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences (CACMS), Beijing, China
Weixin Li
Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences (CACMS), Beijing, China
Minghui Gou
Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences (CACMS), Beijing, China
Introduction The therapeutic needs of women with diminished ovarian reserve (DOR), coupled with the increasing application of acupuncture in improving ovarian function, have highlighted the need to verify the efficacy and safety of acupuncture for DOR. This study aims to provide high-quality evidence by evaluating both ovarian reserve and in vitro fertilisation (IVF) outcomes.Methods and analysis A large-scale, multicentre, randomised controlled trial will be carried out across seven hospitals in China. 400 women with DOR will be randomised in a 1:1 ratio to an acupuncture group or a sham acupuncture group. Acupuncture or sham acupuncture will consist of 36 sessions per participant over 12 weeks. The primary outcome will be the change in antral follicle count (AFC) at week 12 from baseline. Secondary outcomes are AFC at week 24, the serum levels of basal follicle-stimulating hormone and anti-Mullerian hormone at weeks 12 and 24, the scores of the Self-Rating Anxiety Scale at weeks 12 and 24, clinical pregnancy rate, and IVF embryo transfer related outcomes. Any adverse events during treatment will be documented.Ethics and dissemination The study protocol has been approved by all the participating institutions. Written informed consent will be obtained prior to participant enrolment. The results of this study will be published in peer-reviewed publications.Trial registration number ChiCTR2200062295Protocol version V2.0-20220317